SCHEMBL9856926

SCHEMBL9856926

O=C([CH]C1CCNCC1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SIGMAR1 Q99720 2/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.43
PLIN1 O60240 1/20 0.43
BCHE P06276 1/20 0.43
TNFRSF1A P19438 1/20 0.43
ACHE P22303 1/20 0.43
MAOB P27338 1/20 0.43
RECQL P46063 1/20 0.43
PLIN5 Q00G26 1/20 0.43
CYP1B1 Q16678 1/20 0.43
ABHD5 Q8WTS1 1/20 0.43
RAB9A P51151 3/20 0.42
AKT1 P31749 1/20 0.42
NFE2L2 Q16236 1/20 0.41
SLC18A3 Q16572 1/20 0.41
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488747 0.83 ALDH1A1 (0.48) ALDH1A1MAPK1TDP1LMNAMAPT
SCHEMBL10349772 0.74 CHRM3 (0.50) SIGMAR1LMNASLC18A3KMT2AMEN1
SCHEMBL408318 0.72 KMT2A (0.66) SIGMAR1SLC18A3KMT2AMEN1CYP2D6
Benzoic Acid SCHEMBL18838596 0.72 TSHR (0.56) ALDH1A1SIGMAR1LMNASLC18A3KMT2A
SCHEMBL817420 0.71 KDM1A (0.50) SIGMAR1LMNASLC18A3KMT2AMEN1
SCHEMBL594567 0.71 NPC1 (0.62) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL8124713 0.71 LMNA (0.51) ALDH1A1MAPK1TDP1LMNARAB9A
Hydrochloric Acid SCHEMBL227939 0.70 KMT2A (0.69) SIGMAR1SLC18A3KMT2AMEN1CYP2D6
Bromide SCHEMBL10968790 0.70 KMT2A (0.64) SIGMAR1SLC18A3KMT2AMEN1CYP2D6
Water SCHEMBL22462471 0.70 NPC1 (0.60) RAB9ANPC1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0420806-A1 Phosphonic acids, process for preparation and use as an active pharmaceutical composition CIBA-GEIGY AG (CH) 1991-04-03 EP disclosed